Dr. Eytan M. Stein, MD, is a highly regarded hematologic oncologist and physician-scientist at Memorial Sloan Kettering Cancer Center (MSKCC), where he serves as Chief of the Leukemia Service and Director of the Program for Drug Development in Leukemia. He earned his medical degree from Northwestern University Feinberg School of Medicine, followed by an internal medicine residency at NYU Langone Health and a hematology-oncology fellowship at MSKCC. Board-certified in internal medicine, hematology, and medical oncology, Dr. Stein provides expert, personalized care to patients with acute myeloid leukemia (AML), myelodysplastic syndromes (MDS), and related hematologic malignancies.
Why they are a top doctor
Research papers · PubMed
151
Published, peer-reviewed work, the clearest public measure of expertise in a specialty.
Cited by other doctors
18.4k
How often other doctors and researchers build on their work.
Known for
Early drug development and early-phase clinical trials
The distinction that sets them apart from other leukemia specialist & early drug development specialists.
Specializes in
Targeted therapy
A narrow focus means they see far more of these cases than a general oncologist.
Background
Education
Medical school: Northwestern University Medical School
Residency: Internal Medicine, Northwestern Memorial Hospital
Fellowships: Medical Oncology/Hematology, Memorial Sloan Kettering Cancer Center
Board certifications: Internal Medicine · Hematology · Medical Oncology
Awards
Louise and Allston Boyer Young Investigator Award for Clinical Research, MSK
Willet F. Whitmore Award for Clinical Excellence, MSK
Memberships and affiliations
Leukemia Service, Memorial Sloan Kettering Cancer Center
Program for Drug Development in Leukemia, MSK
Associate Professor of Medicine, Weill Cornell Medical College
American Society of Hematology (ASH) - Precision Medicine Initiative